Showing results (1191-1200 of 5,120) with videos related to
Sort By:
Pageof 512
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|November 19, 1997
Castleman's disease: an unusual cause of a neck massB N Kumar, T J Jones, D W SkinnerBritish Journal of Cancer|July 17, 2003
Photodynamic therapy effect of m-THPC (Foscan) in vivo: correlation with pharmacokineticsH J Jones, D I Vernon, S B BrownBiotechniques|April 22, 2003
Development and characterization of the NanoOrange protein quantitation assay: a fluorescence-based assay of proteins in solutionLaurie J Jones, Richard P Haugland, Victoria L SingerThe Annals of Pharmacotherapy|May 30, 2003
Rhabdomyolysis causing AV blockade due to possible atorvastatin, esomeprazole, and clarithromycin interactionBrooke E Sipe, Ronald J Jones, Gordon H BokhartPsychopharmacology|January 1, 1992
Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injectionG A Higgins, B J Jones, N R OakleyNeuropharmacology|April 1, 1982
Adrenergic receptors in rat spinal cordD J Jones, D E Kendall, S J EnnaNeuropharmacology|July 1, 1984
The benzodiazepine receptor ligand CL218,872 has both anxiolytic and sedative properties in rodentsN R Oakley, B J Jones, D W StraughanClinical and Experimental Immunology|January 1, 1995
Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitisM H Zhao, S J Jones, C M LockwoodFEMS Yeast Research|May 16, 2006
Contemplating the murine test tube: lessons from natural killer cells and Cryptococcus neoformansKaleb J Marr, Gareth J Jones, Christopher H ModyThe Cochrane Database of Systematic Reviews|May 26, 2017
WITHDRAWN: Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergyDavid A Osborn, John Kh Sinn, Lisa J JonesPageof 512